Retour
29
Fourchette du Jour
36,00 €
38,09 €
Fourchette 52 Semaines
19,17 €
38,09 €
Volume
617 407
Moyenne 50J / 200J
32,28 €
/
27,21 €
Clôture Précédente
35,62 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 48,0 | 0,4 |
| P/B | 11,5 | 2,9 |
| ROE % | 28,3 | 3,7 |
| Net Margin % | 3,4 | 3,9 |
| Rev Growth 5Y % | 16,3 | 10,0 |
| D/E | 0,2 | 0,2 |
Objectif de Cours des Analystes
Hold
36,00 €
-3.4%
Low: 30,00 €
High: 40,00 €
P/E Prévisionnel
30,2
BPA Prévisionnel
1,24 €
Croissance BPA (est.)
+0,0%
CA Est.
1,4 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2028 |
1,46 €
1,44 € – 1,48 €
|
1,7 B | 2 |
| FY2027 |
1,36 €
1,31 € – 1,40 €
|
1,5 B | 3 |
| FY2026 |
1,24 €
1,21 € – 1,25 €
|
1,4 B | 3 |
Points Clés
Revenue grew 16,29% annually over 5 years — strong growth
ROE of 28,25% indicates high profitability
Debt/Equity of 0,22 — conservative balance sheet
Generating 80,71M in free cash flow
P/E of 47,95 — premium valuation
Cash machine — converts 163,98% of earnings into free cash flow
Croissance
Revenue Growth (5Y)
16,29%
Revenue (1Y)17,93%
Earnings (1Y)N/A
FCF Growth (3Y)19,77%
Qualité
Return on Equity
28,25%
ROIC26,62%
Net Margin3,40%
Op. Margin6,14%
Sécurité
Debt / Equity
0,22
Current Ratio1,38
Interest Coverage133,71
Valorisation
P/E Ratio
47,95
P/B Ratio11,47
EV/EBITDA26,31
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 17,93% | Revenue Growth (3Y) | 17,67% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | 43,50% |
| Revenue Growth (5Y) | 16,29% | Earnings Growth (5Y) | 31,79% |
| Profitability | |||
| Revenue (TTM) | 1,45B | Net Income (TTM) | 49,22M |
| ROE | 28,25% | ROA | 11,93% |
| Gross Margin | 19,47% | Operating Margin | 6,14% |
| Net Margin | 3,40% | Free Cash Flow (TTM) | 80,71M |
| ROIC | 26,62% | FCF Growth (3Y) | 19,77% |
| Safety | |||
| Debt / Equity | 0,22 | Current Ratio | 1,38 |
| Interest Coverage | 133,71 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 47,95 | P/B Ratio | 11,47 |
| P/S Ratio | 1,63 | PEG Ratio | -0,26 |
| EV/EBITDA | 26,31 | Dividend Yield | 0,00% |
| Market Cap | 2,36B | Enterprise Value | 2,34B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,45B | 1,23B | 1,05B | 908,91M | 792,07M |
| Net Income | 49,22M | -87,29M | 23,90M | 35,42M | 16,31M |
| EPS (Diluted) | 0,78 | -1,77 | 0,39 | 0,58 | 0,27 |
| Gross Profit | 282,04M | 244,37M | 208,31M | 185,87M | 161,27M |
| Operating Income | 88,91M | -62,92M | 40,95M | 51,99M | 30,15M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 412,66M | 320,81M | 271,17M | 256,11M | 235,85M |
| Total Liabilities | 194,73M | 170,83M | 211,31M | 180,18M | 182,53M |
| Shareholders' Equity | 205,76M | 142,67M | 28,21M | 42,73M | 23,93M |
| Total Debt | 44,72M | 37,33M | 69,15M | 62,98M | 55,04M |
| Cash & Equivalents | 65,62M | 4,66M | 752 000,0 | 607 000,0 | 15,01M |
| Current Assets | 221,63M | 151,99M | 129,60M | 120,00M | 111,87M |
| Current Liabilities | 160,70M | 144,12M | 138,02M | 112,01M | 111,54M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#836 of 1024
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026